These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 11021572)
1. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. Rodrigues AC; Cara DC; Fretez SH; Cunha FQ; Vieira EC; Nicoli JR; Vieira LQ J Appl Microbiol; 2000 Sep; 89(3):404-14. PubMed ID: 11021572 [TBL] [Abstract][Full Text] [Related]
2. Lactobacillus delbrueckii UFV-H2b20 induces type 1 cytokine production by mouse cells in vitro and in vivo. Neumann E; Ramos MG; Santos LM; Rodrigues AC; Vieira EC; Afonso LC; Nicoli JR; Vieira LQ Braz J Med Biol Res; 2009 Apr; 42(4):358-67. PubMed ID: 19330264 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Martins FS; Silva AA; Vieira AT; Barbosa FH; Arantes RM; Teixeira MM; Nicoli JR Arch Microbiol; 2009 Aug; 191(8):623-30. PubMed ID: 19526225 [TBL] [Abstract][Full Text] [Related]
4. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. Rodrigues AC; Nardi RM; Bambirra EA; Vieira EC; Nicoli JR J Appl Bacteriol; 1996 Sep; 81(3):251-6. PubMed ID: 8810053 [TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory activity of potential probiotic yeast strains in the dorsal air pouch system and the gut mucosa. Kourelis A; Kotzamanidis C; Litopoulou-Tzanetaki E; Papaconstantinou J; Tzanetakis N; Yiangou M J Appl Microbiol; 2010 Jul; 109(1):260-71. PubMed ID: 20059615 [TBL] [Abstract][Full Text] [Related]
6. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Akisu M; Baka M; Yalaz M; Huseyinov A; Kultursay N Eur J Pediatr Surg; 2003 Oct; 13(5):319-23. PubMed ID: 14618522 [TBL] [Abstract][Full Text] [Related]
7. Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Generoso SV; Viana ML; Santos RG; Arantes RM; Martins FS; Nicoli JR; Machado JA; Correia MI; Cardoso VN Eur J Nutr; 2011 Jun; 50(4):261-9. PubMed ID: 20936479 [TBL] [Abstract][Full Text] [Related]
8. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069 [TBL] [Abstract][Full Text] [Related]
9. [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. Liu YT; Li YQ; Wang YZ Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):921-926. PubMed ID: 28073414 [No Abstract] [Full Text] [Related]
10. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. Filho-Lima JV; Vieira EC; Nicoli JR J Appl Microbiol; 2000 Mar; 88(3):365-70. PubMed ID: 10747216 [TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium, Bacteroides thetaiotaomicron, in gnotobiotic rats. Scharek L; Hartmann L; Heinevetter L; Blaut M Immunobiology; 2000 Nov; 202(5):429-41. PubMed ID: 11205373 [TBL] [Abstract][Full Text] [Related]
17. Pais P; Almeida V; Yılmaz M; Teixeira MC J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32512834 [No Abstract] [Full Text] [Related]
18. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Kim SC; Tonkonogy SL; Albright CA; Tsang J; Balish EJ; Braun J; Huycke MM; Sartor RB Gastroenterology; 2005 Apr; 128(4):891-906. PubMed ID: 15825073 [TBL] [Abstract][Full Text] [Related]
19. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Jawhara S; Poulain D Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943 [TBL] [Abstract][Full Text] [Related]
20. Modulation of IL-12 and IFNγ by probiotic supplementation promotes protection against Toxocara canis infection in mice. de Avila LF; de Leon PM; de Moura MQ; Berne ME; Scaini CJ; Leivas Leite FP Parasite Immunol; 2016 May; 38(5):326-30. PubMed ID: 26971490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]